Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enver Akalin

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
Transplantation|November 22, 2023
Impact of Deceased-donor Acute Kidney Injury on Kidney TransplantationHillary C Yaffe, Dagny von Ahrens, Alejandra Urioste, et al.
Clinical Transplantation|April 22, 2016
Pregnancy in sensitized kidney transplant recipients: a single-center experienceMaria Ajaimy, Michelle Lubetzky, Timothy Jones, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 5, 2003
Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxisEnver Akalin, Vinita Sehgal, Scott Ames, et al.
Transplantation|March 24, 2005
Intravenous immunoglobulin and thymoglobulin induction treatment in immunologically high-risk kidney transplant recipientsEnver Akalin, Scott Ames, Vinita Sehgal, et al.
Transplantation|December 6, 2003
Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patientsEnver Akalin, Scott Ames, Vinita Sehgal, et al.
Kidney International|November 5, 2015
The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantationSumeyye Calp-Inal, Maria Ajaimy, Michal L Melamed, et al.
Transplantation|February 16, 2006
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipientsLorenzo Gallon, Enver Akalin, Patrick Lynch, et al.
Clinical Transplantation|June 19, 2015
Kidney transplantation in patients with severe preoperative hypertensionMaria Ajaimy, Michelle Lubetzky, Layla Kamal, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 16, 2005
Chronic organizing microangiopathy in a renal transplant recipientChristina M Wyatt, Steven Dikman, Vinita Sehgal, et al.
Diagnostics (Basel, Switzerland)|May 14, 2025
SARS-CoV-2 Infection Is Associated with an Accelerated eGFR Decline in Kidney Transplant Recipients up to Four Years Post InfectionShawn Qiu, Roham Hadidchi, Aditi Vichare, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Transplantation|November 22, 2023
Impact of Deceased-donor Acute Kidney Injury on Kidney TransplantationHillary C Yaffe, Dagny von Ahrens, Alejandra Urioste, et al.
Clinical Transplantation|April 22, 2016
Pregnancy in sensitized kidney transplant recipients: a single-center experienceMaria Ajaimy, Michelle Lubetzky, Timothy Jones, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 5, 2003
Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxisEnver Akalin, Vinita Sehgal, Scott Ames, et al.
Transplantation|March 24, 2005
Intravenous immunoglobulin and thymoglobulin induction treatment in immunologically high-risk kidney transplant recipientsEnver Akalin, Scott Ames, Vinita Sehgal, et al.
Transplantation|December 6, 2003
Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patientsEnver Akalin, Scott Ames, Vinita Sehgal, et al.
Kidney International|November 5, 2015
The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantationSumeyye Calp-Inal, Maria Ajaimy, Michal L Melamed, et al.
Transplantation|February 16, 2006
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipientsLorenzo Gallon, Enver Akalin, Patrick Lynch, et al.
Clinical Transplantation|June 19, 2015
Kidney transplantation in patients with severe preoperative hypertensionMaria Ajaimy, Michelle Lubetzky, Layla Kamal, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 16, 2005
Chronic organizing microangiopathy in a renal transplant recipientChristina M Wyatt, Steven Dikman, Vinita Sehgal, et al.
Diagnostics (Basel, Switzerland)|May 14, 2025
SARS-CoV-2 Infection Is Associated with an Accelerated eGFR Decline in Kidney Transplant Recipients up to Four Years Post InfectionShawn Qiu, Roham Hadidchi, Aditi Vichare, et al.
Pageof 14